🇺🇸 FDA
Patent

US 11753463

Therapeutic targeting of non-cellular structures

granted A61KA61K2039/505A61K31/704

Quick answer

US patent 11753463 (Therapeutic targeting of non-cellular structures) held by Orionis Biosciences, Inc expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K31/704, A61K38/191, A61K38/212